Methods And Compositions For Nucleic Acid Analysis - EP3395957

EP3395957

BIO RAD LABORATORIES
Application Number
EP18175708A
Filing Date
Apr 25, 2012
Status
Granted And Under Opposition
Jul 10, 2020
Grant Date
Aug 12, 2020
External Links
Slate, Register, Google Patents

Bibliography

The patent EP3395957B1 was granted to BIO RAD Laboratories on Aug 12, 2020 following the initial filing on Apr 25, 2012 under the application number EP18175708A . The current legal status of the patent is Granted And Under Opposition.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BARDEHLE PAGENBERG PARTNERSCHAFT MBB PATENTANWALTEMay 12, 2021WITHDRAWN

Patent Citations New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePatent NumberPatent Link
DESCRIPTIONUS2010022403
DESCRIPTIONUS2010173394
DESCRIPTIONUS2010203538
DESCRIPTIONUS2011033854
DESCRIPTIONUS2011053798
DESCRIPTIONUS4469863
DESCRIPTIONUS4988617
DESCRIPTIONUS5034506
DESCRIPTIONUS5216141
DESCRIPTIONUS5235033
DESCRIPTIONUS5242794
DESCRIPTIONUS5386023
DESCRIPTIONUS5494810
DESCRIPTIONUS5602240
DESCRIPTIONUS5637684
DESCRIPTIONUS5644048
DESCRIPTIONUS5789206
DESCRIPTIONUS6180349
DESCRIPTIONUS6582938
DESCRIPTIONUS7074600
DESCRIPTIONUS7622280
DESCRIPTIONWO2010036352
OPPOSITIONUS2011033854
OPPOSITIONWO2004091763
OPPOSITIONWO2008109176
OPPOSITIONWO2009137606
OPPOSITIONWO2010033200
OPPOSITIONWO2011028539
OPPOSITIONWO2012149042
SEARCHUS2007077572
SEARCHUS2009098555
SEARCHUS2011033854
SEARCHWO2007001448
SEARCHWO2008134153

Non-Patent Literature (NPL) Citations New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BEAUCAGE et al., Tetrahedron, (19930000), vol. 49, no. 10, page 1925-
DESCRIPTION- BRIU et al., J. Am. Chem. Soc., (19890000), vol. 111, page 2321-
DESCRIPTION- BROWN et al., Methods Enzymol., (19790000), vol. 68, page 109-
DESCRIPTION- CARLSSON et al., Nature, (19960000), vol. 380, page 207-
DESCRIPTION- "Chapter 2 and 3", Y. S. Sanghui and P. Dan Cook, ASC Symposium Series 580, "Carbohydrate Modifications in Antisense Research"-
DESCRIPTION- DENPCY et al., Proc. Natl. Acad. Sci. USA, (19950000), vol. 92, page 6097-
DESCRIPTION- DRMANAC et al., Science, (20100000), vol. 327, pages 78 - 81-
DESCRIPTION- ECKSTEIN, Oligonucleotides and Analogues: A Practical Approach, Oxford University Press-
DESCRIPTION- EGHOLM, J. Am. Chem. Soc., (19920000), vol. 114, page 1895-
DESCRIPTION- GARAJ et al., Nature, (20100000), vol. 67-
DESCRIPTION- GURRIERI S; BUSTAMANTE C., Biochem J., (19970000), vol. 326, pages 131 - 138-
DESCRIPTION- HARRIS T. D. et al., Science, (20080000), vol. 320, pages 106 - 109-
DESCRIPTION- HUSE et al., Science, (19890000), vol. 246, pages 1275 - 1281-
DESCRIPTION- JEFFS et al., J. Biomolecular NMR, (19940000), vol. 34, page 17-
DESCRIPTION- JENKINS et al., Chem. Soc. Rev., (19950000), pages 169 - 176-
DESCRIPTION- KIEDROWSHI et al., Angew. Chem. Intl. Ed. English, (19910000), vol. 30, page 423-
DESCRIPTION- KOSHKIN et al., J. Am. Chem. Soc., (19980000), vol. 120.1325, page 3-
DESCRIPTION- KOVACIC et al., Nucleic Acids Research, (19950000), vol. 23, pages 3999 - 4000-
DESCRIPTION- LETSINGER et al., J. Am. Chem. Soc., (19880000), vol. 110, page 4470-
DESCRIPTION- LETSINGER et al., Nucl. Acids Res., (19860000), vol. 14, page 3487-
DESCRIPTION- LETSINGER et al., Nucleoside & Nucleotide, (19940000), vol. 13, page 1597-
DESCRIPTION- LETSINGER, J. Org. Chem., (19700000), vol. 35, page 3800-
DESCRIPTION- MAG et al., Nucleic Acids Res., (19910000), vol. 19, page 1437-
DESCRIPTION- MARGULIES, M et al., Nature, (20050000), vol. 437, pages 376 - 380-
DESCRIPTION- MEIER et al., Chem. Int. Ed. Engl., (19920000), vol. 31, page 1008-
DESCRIPTION- MESMAEKER et al., Bioorganic & Medicinal Chem. Lett., (19940000), vol. 4, page 395-
DESCRIPTION- NARANG et al., Methods Enzymol., (19790000), vol. 68, page 90-
DESCRIPTION- NIELSEN, Nature, (19930000), vol. 365, page 566-
DESCRIPTION- PAUWELS et al., Chemica Scripta, vol. 26, page 141-
DESCRIPTION- RAWLS, C, E News, (19970602), page 35-
DESCRIPTION- SAWAI et al., Chem. Lett., (19840000), vol. 805-
DESCRIPTION- SONI GV; MELLER A, Clin Chem, (20070000), vol. 53, pages 1996 - 2001-
DESCRIPTION- SPRINZL et al., Eur. J. Biochem., (19770000), vol. 81, page 579-
DESCRIPTION- TAYLOR et al., PLoS One, (20080000), vol. 3, no. 9, page e3179-
DESCRIPTION- Tetrahedron Lett., (19960000), vol. 37, page 743-
DESCRIPTION- WARD et al., Nature, (19890000), vol. 341, pages 544 - 546-
DESCRIPTION- WINTER; HARRIS, Immunol. Today, (19930000), vol. 14, pages 243 - 246-
DESCRIPTION- REDON et al., "Global variation in copy number in the human genome", Nature, (20060000), vol. 444, doi:doi:10.1038/nature05329, pages 444 - 454, XP008120970
SEARCH- JARROD A. HANSON ET AL, "Nanoscale double emulsions stabilized by single-component block copolypeptides", NATURE, (20080904), vol. 455, no. 7209, doi:10.1038/nature07197, ISSN 0028-0836, pages 85 - 88, XP055175302 [A] 1-12 * the whole document *
SEARCH- YOLANDA SCHAERLI AND FLORIAN HOLLFELDER, "The potential of microfluidic water-in-oil droplets in experimental biology", MOLECULAR BIOSYSTEMS, ROYAL SOCIETY OF CHEMISTRY, GB, vol. 5, no. 12, doi:10.1039/B907578J, ISSN 1742-206X, (20091201), pages 1392 - 1404, (20091012), XP002669720 [A] 1-12 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents